Cargando…
Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
The incidence of end-stage renal disease (ESRD) in Japanese patients with type 1 diabetes mellitus (T1DM) was investigated regarding the association between mean HbA1c values during follow-up and the duration of follow-up/illness. The study includes 988 patients diagnosed at ages younger than 30 yr....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801355/ https://www.ncbi.nlm.nih.gov/pubmed/31666764 http://dx.doi.org/10.1297/cpe.28.113 |
_version_ | 1783460552965619712 |
---|---|
author | Otani, Toshika Yokoyama, Hiroki Hanai, Ko Miura, Junnosuke Uchigata, Yasuko Babazono, Tetsuya |
author_facet | Otani, Toshika Yokoyama, Hiroki Hanai, Ko Miura, Junnosuke Uchigata, Yasuko Babazono, Tetsuya |
author_sort | Otani, Toshika |
collection | PubMed |
description | The incidence of end-stage renal disease (ESRD) in Japanese patients with type 1 diabetes mellitus (T1DM) was investigated regarding the association between mean HbA1c values during follow-up and the duration of follow-up/illness. The study includes 988 patients diagnosed at ages younger than 30 yr. These patients were initially examined between 1962 and 1999, and HbA1 and/or HbA1c measurements were taken for at least 3 yr after 1980. The follow-up period was from the date of the first HbA1 or HbA1c measurement to the final measurement day, or HbA1c measurement day immediately before the development of ESRD. The condition progressed to ESRD in 63 patients (mean duration of illness: 23.6 yr). Cox regression analysis revealed that patients with HbA1c of ≥ 10% had a significantly increased higher risk than those with HbA1c under 8% (P < 0.0001). The HbA1c cut-off point was 10.0%. The HbA1c value was ≥ 10% at baseline and during follow-up in 128 patients. Assuming that HbA1c of ≥ 10% persisted since the time of diagnosis in these patients, the cumulative incidence of ESRD abruptly increased after 15 yr of illness. Thus, the incidence of ESRD increased after the persistence of HbA1c of ≥ 10% for 15 yr. |
format | Online Article Text |
id | pubmed-6801355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Japanese Society for Pediatric Endocrinology |
record_format | MEDLINE/PubMed |
spelling | pubmed-68013552019-10-30 Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years Otani, Toshika Yokoyama, Hiroki Hanai, Ko Miura, Junnosuke Uchigata, Yasuko Babazono, Tetsuya Clin Pediatr Endocrinol Original Article The incidence of end-stage renal disease (ESRD) in Japanese patients with type 1 diabetes mellitus (T1DM) was investigated regarding the association between mean HbA1c values during follow-up and the duration of follow-up/illness. The study includes 988 patients diagnosed at ages younger than 30 yr. These patients were initially examined between 1962 and 1999, and HbA1 and/or HbA1c measurements were taken for at least 3 yr after 1980. The follow-up period was from the date of the first HbA1 or HbA1c measurement to the final measurement day, or HbA1c measurement day immediately before the development of ESRD. The condition progressed to ESRD in 63 patients (mean duration of illness: 23.6 yr). Cox regression analysis revealed that patients with HbA1c of ≥ 10% had a significantly increased higher risk than those with HbA1c under 8% (P < 0.0001). The HbA1c cut-off point was 10.0%. The HbA1c value was ≥ 10% at baseline and during follow-up in 128 patients. Assuming that HbA1c of ≥ 10% persisted since the time of diagnosis in these patients, the cumulative incidence of ESRD abruptly increased after 15 yr of illness. Thus, the incidence of ESRD increased after the persistence of HbA1c of ≥ 10% for 15 yr. The Japanese Society for Pediatric Endocrinology 2019-10-19 2019 /pmc/articles/PMC6801355/ /pubmed/31666764 http://dx.doi.org/10.1297/cpe.28.113 Text en 2019©The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Otani, Toshika Yokoyama, Hiroki Hanai, Ko Miura, Junnosuke Uchigata, Yasuko Babazono, Tetsuya Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years |
title | Rapid increase in the incidence of end-stage renal disease in patients with
type 1 diabetes having HbA1c 10% or higher for 15 years |
title_full | Rapid increase in the incidence of end-stage renal disease in patients with
type 1 diabetes having HbA1c 10% or higher for 15 years |
title_fullStr | Rapid increase in the incidence of end-stage renal disease in patients with
type 1 diabetes having HbA1c 10% or higher for 15 years |
title_full_unstemmed | Rapid increase in the incidence of end-stage renal disease in patients with
type 1 diabetes having HbA1c 10% or higher for 15 years |
title_short | Rapid increase in the incidence of end-stage renal disease in patients with
type 1 diabetes having HbA1c 10% or higher for 15 years |
title_sort | rapid increase in the incidence of end-stage renal disease in patients with
type 1 diabetes having hba1c 10% or higher for 15 years |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801355/ https://www.ncbi.nlm.nih.gov/pubmed/31666764 http://dx.doi.org/10.1297/cpe.28.113 |
work_keys_str_mv | AT otanitoshika rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years AT yokoyamahiroki rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years AT hanaiko rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years AT miurajunnosuke rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years AT uchigatayasuko rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years AT babazonotetsuya rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years |